![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PFIZER WINS NORVASC PATENT CHALLENGE BY GENERIC MANUFACTURER SYNTHON
PFIZER WINS NORVASC PATENT CHALLENGE BY GENERIC MANUFACTURER SYNTHON
Pfizer Inc said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension. The patent had been challenged by the generic manufacturer, Synthon
Pharmaceuticals.
Yahoo
Finance
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct